Antigua and Barbuda vs Mus: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Antigua and Barbuda
100.0%
in 2014
Mus
100.0%
in 2014
Antigua and Barbuda rank
1st
Mus rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Antigua and Barbuda
- Mus
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2004 it was Mus ahead.
Antigua and Barbuda ranks 1st and Mus ranks 1st of 104 countries.
Across the 2 decades both report, Antigua and Barbuda averaged higher in 1 and Mus in 1.
Head to head by decade
| Decade | Antigua and Barbuda | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 93.3% | 6.7% | Antigua and Barbuda |
| 2010s | 78.0% | 100.0% | 22.0% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Antigua and Barbuda or Mus?
- Antigua and Barbuda, at 100.0% against 100.0% in Mus as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Antigua and Barbuda and Mus?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Mus?
- 8 years are reported by both, from 2004 to 2014.
- How do Antigua and Barbuda and Mus rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Antigua and Barbuda ranks 1st and Mus ranks 1st of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.